What is Barrington Research’s Estimate for DLB Q3 Earnings?

Dolby Laboratories, Inc. (NYSE:DLB) – Stock analysts at Barrington Research cut their Q3 2025 earnings per share estimates for shares of Dolby Laboratories in a research report issued to clients and investors on Wednesday, November 20th. Barrington Research analyst J. Goss now forecasts that the electronics maker will post earnings of $0.50 per share for the quarter, down from their prior estimate of $0.52. Barrington Research has a “Outperform” rating and a $100.00 price objective on the stock. The consensus estimate for Dolby Laboratories’ current full-year earnings is $2.67 per share.

Other equities analysts have also issued reports about the company. StockNews.com upgraded Dolby Laboratories from a “buy” rating to a “strong-buy” rating in a report on Monday, November 18th. Rosenblatt Securities raised their price target on shares of Dolby Laboratories from $98.00 to $100.00 and gave the stock a “buy” rating in a research report on Wednesday, November 20th.

Dolby Laboratories Stock Up 0.4 %

Shares of NYSE DLB opened at $80.55 on Monday. Dolby Laboratories has a 12 month low of $66.35 and a 12 month high of $90.06. The company has a market cap of $7.68 billion, a price-to-earnings ratio of 29.72 and a beta of 0.98. The business has a fifty day simple moving average of $74.33 and a 200-day simple moving average of $75.98.

Hedge Funds Weigh In On Dolby Laboratories

Institutional investors have recently added to or reduced their stakes in the business. Boston Trust Walden Corp raised its stake in shares of Dolby Laboratories by 185.3% in the third quarter. Boston Trust Walden Corp now owns 1,075,076 shares of the electronics maker’s stock worth $82,276,000 after purchasing an additional 698,283 shares during the last quarter. Clifford Capital Partners LLC boosted its stake in shares of Dolby Laboratories by 3,114.7% in the 3rd quarter. Clifford Capital Partners LLC now owns 270,579 shares of the electronics maker’s stock valued at $20,707,000 after purchasing an additional 262,162 shares in the last quarter. Acadian Asset Management LLC grew its stake in shares of Dolby Laboratories by 39.8% during the second quarter. Acadian Asset Management LLC now owns 652,651 shares of the electronics maker’s stock valued at $51,698,000 after buying an additional 185,884 shares during the last quarter. Dimensional Fund Advisors LP grew its position in Dolby Laboratories by 27.0% during the 2nd quarter. Dimensional Fund Advisors LP now owns 792,828 shares of the electronics maker’s stock worth $62,817,000 after acquiring an additional 168,744 shares during the last quarter. Finally, AQR Capital Management LLC increased its stake in shares of Dolby Laboratories by 16.2% in the second quarter. AQR Capital Management LLC now owns 627,160 shares of the electronics maker’s stock worth $49,690,000 after buying an additional 87,298 shares during the period. 58.56% of the stock is owned by institutional investors and hedge funds.

Insider Activity

In related news, Director Peter C. Gotcher sold 6,079 shares of the company’s stock in a transaction that occurred on Thursday, November 21st. The shares were sold at an average price of $78.96, for a total transaction of $479,997.84. Following the completion of the transaction, the director now directly owns 37,593 shares in the company, valued at $2,968,343.28. This represents a 13.92 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Kevin J. Yeaman sold 28,512 shares of the firm’s stock in a transaction on Tuesday, October 15th. The shares were sold at an average price of $74.12, for a total transaction of $2,113,309.44. Following the transaction, the chief executive officer now directly owns 83,721 shares of the company’s stock, valued at $6,205,400.52. The trade was a 25.40 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 39.54% of the company’s stock.

Dolby Laboratories announced that its board has authorized a stock repurchase plan on Wednesday, August 7th that authorizes the company to repurchase $350.00 million in outstanding shares. This repurchase authorization authorizes the electronics maker to buy up to 5% of its stock through open market purchases. Stock repurchase plans are typically an indication that the company’s leadership believes its stock is undervalued.

Dolby Laboratories Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Tuesday, December 10th. Shareholders of record on Tuesday, December 3rd will be issued a dividend of $0.33 per share. This is an increase from Dolby Laboratories’s previous quarterly dividend of $0.30. This represents a $1.32 annualized dividend and a yield of 1.64%. The ex-dividend date is Tuesday, December 3rd. Dolby Laboratories’s dividend payout ratio (DPR) is 44.28%.

About Dolby Laboratories

Dolby Laboratories, Inc creates audio and imaging technologies that transform entertainment at the cinema, DTV transmissions and devices, mobile devices, OTT video and music services, home entertainment devices, and automobiles. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, a digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and various media devices.